KPJ Healthcare Berhad highlighted steady progress under its evolving health system model as it convened its 33rd Annual General Meeting, backed by a solid financial performance for the financial year ended 2025 (FY2025).
The group recorded revenue of RM4.26 billion, marking a 9% increase from RM3.90 billion in FY2024. Profit before tax rose 6% to RM563 million, while profit after tax climbed 10% to RM402 million, reflecting continued operational resilience and improved returns to shareholders.
Chairman Tan Sri Dr Ismail Haji Bakar said the results underscore KPJ’s ongoing transformation into an integrated healthcare system that brings together clinical care, education, research and innovation.
“FY2025 reflects our transition from a hospital network into a fully integrated health system. This approach strengthens our ability to deliver high-quality care, nurture future healthcare talent and drive innovation, while creating sustainable value for patients, communities and shareholders,” he said.
He added that the group remains committed to expanding access to quality healthcare while delivering long-term impact through purposeful and resilient growth.
President and managing director Chin Keat Chyuan said KPJ made significant strides during the year in clinical excellence, talent development and innovation, while reinforcing its foundations for future expansion.
“Our focus now is to scale these capabilities across the network through system integration, the development of Centres of Excellence, and the adoption of emerging healthcare technologies such as artificial intelligence, genomics and value-based care,” he said.
Across its network, KPJ reported continued progress in specialised care, workforce development and innovation, in line with its KPJ Health System framework.
Among key milestones were the launch of a Heart and Lung Centre of Excellence at Johor Specialist Hospital, as well as several clinical firsts within the group, including the private sector’s first Pressurised Intraperitoneal Aerosol Chemotherapy (PIPAC) procedure in Malaysia and the introduction of Deep Brain Stimulation (DBS) surgery.
The group also strengthened strategic collaborations, including ongoing ties with Mayo Clinic, expanded training programmes via its School of Digital Health and AI Academy, and introduced new innovation initiatives such as a research management system, a digital health collaboration with the University of Melbourne, and an AI-powered patient engagement chatbot developed with IBM Malaysia.
Looking ahead, KPJ has outlined key priorities for FY2026, including the launch of a Neuroscience and Stroke Centre of Excellence at Damansara Specialist Hospital 2, the successful execution of kidney transplant procedures at Tawakkal Specialist Hospital, and a memorandum of understanding with the Royal College of Surgeons of England to further enhance clinical excellence and talent development.
Moving forward, the group aims to deepen integration across its network while accelerating the rollout of Centres of Excellence and expanding the adoption of advanced technologies to support more personalised and outcome-driven care.
As Malaysia’s first private integrated academic health system, KPJ said it remains committed to translating these efforts into improved health outcomes and sustainable value for the communities it serves. – June 17, 2026
